Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis

Annals of Pharmacotherapy

Volumn 42, Issue 7-8, 2008, Pages 940-946

  Zeigler, Amy J ^a   McAllen, Karen J ^b   Slot, Martha G ^c   Barletta, Jeffrey F ^c  

^a Central Michigan Community Hospital   (United States)

^b Critical Care   (United States)

^c SPECTRUM HEALTH   (United States)

Author keywords

Intensive care unit; Prophylaxis; Stress ulcer

Indexed keywords

ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; GASTROINTESTINAL AGENT; HYPERTENSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; EVIDENCE BASED PRACTICE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; OUTCOME ASSESSMENT; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK FACTOR; STANDARD; STATISTICAL SIGNIFICANCE; STRESS ULCER; SURGICAL PATIENT;

ADULT; AGED; ANTI-ULCER AGENTS; CONTINUITY OF PATIENT CARE; DRUG UTILIZATION; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HUMANS; INPATIENTS; INTENSIVE CARE UNITS; MICHIGAN; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; PATIENT TRANSFER; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH ULCER; STRESS, PSYCHOLOGICAL;

EID: 48249107882     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L123     Document Type: Article

References (20)

1. The Joint Commission. 2006 National Patient Safety Goals. www.jointcommission.org (accessed 2006 Aug 31).
2. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996;275:308-14.
3. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998;338:791-7.
4. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
5. Barletta JF, Erstad BL, Fortune JB. Stress ulcer prophylaxis in trauma patients. Crit Care 2002;6:526-30.
6. Daley RJ, Rebuck JA, Welage LS, Rogers FB. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004;32:2008-13.
7. Erstad BL, Barletta JF, Jacobi J, Killian AD, Kramer KM, Martin SJ. Survey of stress ulcer prophylaxis. Crit Care 1999;3:145-9.
8. Lam NP, Le PD, Crawford SY, Patel S. National survey of stress ulcer prophylaxis. Crit Care Med 1999;27:98-103.
9. Rebuck JA, Murphy C, Stevens A, et al. Does initiation of stress ulcer prophylaxis in the intensive care unit lead to therapy continuation (abstract)? Crit Care Med 2006;34:A150.
10. Wohlt PD, Hansen LA, Fish JT. Inappropriate continuation of stress ulcer prophylactic therapy after discharge. Ann Pharmacother 2007;41:1611-6. Epub 11 Sept 2007. DOI 10.1345/aph.1K227
11. Pronovost P, Weast B, Schwarz M, et al. Medication reconciliation: a practical tool to reduce the risk of medication errors. J Crit Care 2003;18:201-5.
12. Kwan Y, Fernandes OA, Nagge JJ, et al. Pharmacist medication assessments in a surgical preadmission clinic. Arch Intern Med 2007;167:1034-40.
13. Varkey P, Cunningham J, O'Meara J, Bonacci R, Desai N, Sheeler R. Multidisciplinary approach to inpatient medication reconciliation in an academic setting. Am J Health Syst Pharm 2007;64:850-4.
14. Vira T, Colquhoun M, Etchells E. Reconcilable differences: correcting medication errors at hospital admission and discharge. Qual Saf Health Care 2006;15:122-6.
15. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm 1999;56:347-79.
16. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994;330:377-81.
17. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004;171:33-8.
18. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989-95.
19. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003;54:243-5.
20. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol 2006;101:2200-5.